Knowledge, Attitude and Conspiracy Beliefs of Healthcare Workers in Lebanon towards Monkeypox.

Diana Malaeb, Malik Sallam, Nesreen A Salim, Mariam Dabbous, Samar Younes, Yves Nasrallah, Katia Iskandar, Matta Matta, Sahar Obeid, Souheil Hallit, Rabih Hallit
Author Information
  1. Diana Malaeb: College of Pharmacy, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates.
  2. Malik Sallam: Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan. ORCID
  3. Nesreen A Salim: Prosthodontic Department, School of Dentistry, The University of Jordan, Amman 11942, Jordan. ORCID
  4. Mariam Dabbous: School of Pharmacy, Lebanese International University, Beirut P.O. Box 146404, Lebanon. ORCID
  5. Samar Younes: Department of Biomedical Sciences, School of Pharmacy, Lebanese International University, Bekaa P.O. Box 146404, Lebanon. ORCID
  6. Yves Nasrallah: School of Medicine & Medical Sciences, Holy Spirit University of Kaslik, Beirut, Lebanon. ORCID
  7. Katia Iskandar: Pharmaceutical Sciences Department, School of Pharmacy, Lebanese International University, Bekaa P.O. Box 146404, Lebanon. ORCID
  8. Matta Matta: Department of Infectious and Tropical Diseases, Center Hospitalier de Melun, 77000 Melun, France. ORCID
  9. Sahar Obeid: Department of Social and Education Sciences, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
  10. Souheil Hallit: School of Medicine & Medical Sciences, Holy Spirit University of Kaslik, Beirut, Lebanon. ORCID
  11. Rabih Hallit: School of Medicine & Medical Sciences, Holy Spirit University of Kaslik, Beirut, Lebanon.

Abstract

The emergence of a monkeypox (MPOX) outbreak in 2022 represented the most recent recognizable public health emergency at a global level. Improving knowledge and attitude towards MPOX, particularly among healthcare workers (HCWs), can be a valuable approach in public health preventive efforts aiming to halt MPOX virus spread. The aim of the current study was to evaluate the knowledge and attitude of HCWs in Lebanon towards MPOX and to assess their conspiratorial attitude towards emerging virus infections (EVIs). The current study was based on a cross-sectional online survey distributed via Google Forms during September-December 2022 implementing a convenience sampling approach. The final study sample comprised a total of 646 HCWs: physicians ( = 171, 26.5%), pharmacists ( = 283, 43.8%), and nurses ( = 168, 26.0%), among others ( = 24, 3.7%). Variable defects in MPOX knowledge were detected, with a third of the participants having MPOX knowledge above the 75th percentile ( = 218, 33.7%). Satisfactory attitude towards MPOX (>75th percentile) was observed in less than a third of the participants ( = 198, 30.7%), while a quarter of the study sample endorsed conspiracy beliefs towards EVIs at a high level (>75th percentile, = 164, 25.4%). Slightly more than two thirds of the participants agreed that MPOX vaccination should be used in disease prevention ( = 440, 68.1%). Better levels of MPOX knowledge and attitude were significantly associated with postgraduate education and older age. Physicians had significantly higher MPOX knowledge compared to other occupational categories. Less endorsement of conspiracies towards EVIs was significantly associated with male sex, occupation as a physician, and postgraduate education. Higher MPOX knowledge was associated with better attitude towards the disease. The current study showed unsatisfactory MPOX knowledge among Lebanese HCWs. Educational efforts can be valuable to improve the attitude towards the disease. Despite the relatively low level of embracing conspiracy beliefs regarding EVIs among HCWs in this study compared to previous studies, this area should be considered based on its potential impact on health-seeking behavior.

Keywords

References

  1. Healthcare (Basel). 2022 Sep 08;10(9): [PMID: 36141334]
  2. PLoS Med. 2010 Aug;8(8):e1000444 [PMID: 21829329]
  3. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141 [PMID: 35148313]
  4. Narra J. 2022 Dec;2(3):e90 [PMID: 38449905]
  5. Psychol Med. 2023 Apr;53(6):2514-2521 [PMID: 34641992]
  6. Am J Infect Control. 2017 Apr 1;45(4):384-388 [PMID: 28087169]
  7. Curr Opin Virol. 2012 Jun;2(3):335-43 [PMID: 22709519]
  8. Int J Infect Dis. 2023 Feb;127:150-161 [PMID: 36470502]
  9. Pathogens. 2022 Nov 01;11(11): [PMID: 36365036]
  10. New Microbes New Infect. 2022 Nov-Dec;49:101030 [PMID: 36123971]
  11. Pathog Glob Health. 2020 Mar;114(2):68-75 [PMID: 32202967]
  12. Trop Med Infect Dis. 2022 Nov 30;7(12): [PMID: 36548666]
  13. Signal Transduct Target Ther. 2022 Nov 2;7(1):373 [PMID: 36319633]
  14. Emerg Infect Dis. 2020 Apr;26(4):782-785 [PMID: 32023204]
  15. J Multidiscip Healthc. 2022 Jan 11;15:21-45 [PMID: 35046661]
  16. Microorganisms. 2022 Aug 12;10(8): [PMID: 36014051]
  17. Acta Trop. 2020 Jun;206:105450 [PMID: 32194068]
  18. JAMA. 2020 Jun 23;323(24):2458-2459 [PMID: 32421155]
  19. Infect Drug Resist. 2019 Nov 07;12:3445-3453 [PMID: 31807035]
  20. Vaccines (Basel). 2022 Nov 26;10(12): [PMID: 36560432]
  21. Emerg Infect Dis. 2020 Aug;26(8):1826-1830 [PMID: 32338590]
  22. Int J Environ Res Public Health. 2020 Jul 08;17(14): [PMID: 32650409]
  23. Vaccines (Basel). 2022 Sep 28;10(10): [PMID: 36298494]
  24. Infect Dis Rep. 2022 Nov 14;14(6):855-883 [PMID: 36412745]
  25. Genet Mol Biol. 2021 Jan 29;44(1 Suppl 1):e20200256 [PMID: 33533395]
  26. Cureus. 2022 May 26;14(5):e25367 [PMID: 35769680]
  27. Vaccines (Basel). 2022 Aug 19;10(8): [PMID: 36016243]
  28. Viruses. 2022 Sep 29;14(10): [PMID: 36298710]
  29. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  30. PLoS One. 2020 Dec 3;15(12):e0243264 [PMID: 33270783]
  31. J Pharm Policy Pract. 2023 Mar 7;16(1):39 [PMID: 36882801]
  32. Antibiotics (Basel). 2019 Apr 12;8(2): [PMID: 31013803]
  33. New Microbes New Infect. 2022 Dec 17;51:101069 [PMID: 36593883]
  34. Vaccines (Basel). 2021 Jan 12;9(1): [PMID: 33445581]
  35. Trop Med Infect Dis. 2022 Sep 29;7(10): [PMID: 36288017]
  36. J Med Virol. 2023 Jan;95(1):e28294 [PMID: 36367155]
  37. Psychol Med. 2022 Jan;52(2):251-263 [PMID: 32436485]
  38. Vaccines (Basel). 2021 Jun 25;9(7): [PMID: 34202298]
  39. Vaccines (Basel). 2022 Dec 15;10(12): [PMID: 36560561]
  40. Clin Infect Dis. 2010 Jun 15;50(12):1636-40 [PMID: 20450416]
  41. Soc Sci Med. 2022 May;301:114912 [PMID: 35354105]
  42. Vaccines (Basel). 2022 Dec 03;10(12): [PMID: 36560481]
  43. Pathogens. 2022 Aug 31;11(9): [PMID: 36145426]
  44. Nat Med. 2022 Aug;28(8):1569-1572 [PMID: 35750157]
  45. Inquiry. 2022 Jan-Dec;59:469580221139366 [PMID: 36484333]
  46. J Infect Public Health. 2018 May - Jun;11(3):405-411 [PMID: 28970096]
  47. Trop Med Infect Dis. 2022 Oct 03;7(10): [PMID: 36288024]
  48. Vaccines (Basel). 2022 Jun 15;10(6): [PMID: 35746556]
  49. Vaccines (Basel). 2022 Dec 08;10(12): [PMID: 36560508]
  50. Trop Med Infect Dis. 2022 Jul 14;7(7): [PMID: 35878146]
  51. Vaccines (Basel). 2022 Dec 21;11(1): [PMID: 36679864]
  52. Vaccines (Basel). 2021 Apr 01;9(4): [PMID: 33915695]
  53. Int J Environ Res Public Health. 2022 Feb 08;19(3): [PMID: 35162919]
  54. Trop Med Infect Dis. 2016 Dec 20;1(1): [PMID: 30270859]
  55. Vaccines (Basel). 2022 Dec 20;11(1): [PMID: 36679855]
  56. Medicina (Kaunas). 2022 Jul 11;58(7): [PMID: 35888642]
  57. PLoS One. 2022 Dec 1;17(12):e0278622 [PMID: 36454991]
  58. Microb Drug Resist. 2019 Apr;25(3):371-385 [PMID: 30681401]
  59. J Pharm Policy Pract. 2023 Jun 13;16(1):72 [PMID: 37312223]
  60. Viruses. 2020 Dec 30;13(1): [PMID: 33396609]

Word Cloud

Created with Highcharts 10.0.0MPOXtowardsknowledge=attitudestudyamongHCWsEVIslevelcurrent7%participantspercentilediseasesignificantlyassociatedemergenceoutbreak2022publichealthhealthcarecanvaluableapproacheffortsvirusLebanonbasedsurveysample26third>75thconspiracybeliefspostgraduateeducationcomparedmonkeypoxrepresentedrecentrecognizableemergencyglobalImprovingparticularlyworkerspreventiveaiminghaltspreadaimevaluateassessconspiratorialemerginginfectionscross-sectionalonlinedistributedviaGoogleFormsSeptember-Decemberimplementingconveniencesamplingfinalcomprisedtotal646HCWs:physicians1715%pharmacists283438%nurses1680%others243Variabledefectsdetected75th21833Satisfactoryobservedless19830quarterendorsedhigh164254%Slightlytwothirdsagreedvaccinationusedprevention440681%BetterlevelsolderagePhysicianshigheroccupationalcategoriesLessendorsementconspiraciesmalesexoccupationphysicianHigherbettershowedunsatisfactoryLebaneseEducationalimproveDespiterelativelylowembracingregardingpreviousstudiesareaconsideredpotentialimpacthealth-seekingbehaviorKnowledgeAttitudeConspiracyBeliefsHealthcareWorkersMonkeypoxKAPMiddleEastawarenessinternationalconcernresponsepreparedness

Similar Articles

Cited By (20)